INVESTOR AGREEMENT By and Between GLAXO GROUP LIMITED AND WAVE LIFE SCIENCES LTD. Dated as of January 26, 2023Investor Agreement • March 23rd, 2023 • Wave Life Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMarch 23rd, 2023 Company Industry Jurisdiction
INVESTOR AGREEMENT By and Between TAKEDA PHARMACEUTICAL COMPANY LIMITED AND WAVE LIFE SCIENCES LTD. Dated as of April 2, 2018Investor Agreement • May 9th, 2018 • Wave Life Sciences Ltd. • Pharmaceutical preparations • New York
Contract Type FiledMay 9th, 2018 Company Industry JurisdictionTHIS INVESTOR AGREEMENT (this “Agreement”) is made as of April 2, 2018, by and among Takeda Pharmaceutical Company Limited, a company incorporated under the laws of Japan (the “Investor”), and Wave Life Sciences Ltd., a Singapore public limited company (the “Company”).